TGF-β1-Licensed Murine MSCs Show Superior Therapeutic Efficacy in Modulating Corneal Allograft Immune Rejection In Vivo

Overview of attention for article published in Molecular Therapy, May 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

twitter: 24 X users

Citations

dimensions_citation: 39 Dimensions

Readers on

mendeley: 39 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 32 X posts from 24 X users, with an upper bound of 19,969 followers.

Lots of freshly published data on TGF-β licensing of MSCs. Very interesting data on inducing a different phenotype that is more immunosuppressive. More: https://t.co/EDIFS7nMSi

14 Oct 2020

Reply Repost Favourite

Thanks for 🇮🇪 flagging this @ThomasR55937842!

03 Sep 2020

Reply Repost Favourite

RT @ThomasR55937842: Delighted that the final open access version our article is now available! Great team effort and many thanks to all in…

02 Sep 2020

Reply Repost Favourite

RT @ThomasR55937842: Delighted that the final open access version our article is now available! Great team effort and many thanks to all in…

02 Sep 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 28 additional X posts.